Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: A systematic review

Advances in Therapy

Volumn 26, Issue 2, 2009, Pages 170-184

  Verbeeck, Wim ^a   Tuinier, Siegfried ^a   Bekkering, Geertruida E ^b  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adult; Antidepressant agents; Attention deficit hyperactivity disorders; Systematic review; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; LITHIUM; LITHIUM CARBONATE; MAPROTILINE; METHADONE; METHYLPHENIDATE; MOCLOBEMIDE; NORTRIPTYLINE; PARGYLINE; PAROXETINE; PLACEBO; REBOXETINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BULIMIA; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FIBROMYALGIA; FIRST PASS EFFECT; GENERALIZED ANXIETY DISORDER; HEART ARRHYTHMIA; HUMAN; INSOMNIA; LOW DRUG DOSE; MIGRAINE; NARCOLEPSY; NEUROPATHIC PAIN; NOCTURNAL ENURESIS; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PEPTIC ULCER; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SMOKING CESSATION; SOCIAL PHOBIA; SUSTAINED RELEASE FORMULATION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; WEIGHT GAIN;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUPROPION; COMORBIDITY; DESIPRAMINE; EVIDENCE-BASED MEDICINE; HUMANS; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITORS; PAROXETINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 73449134461     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0008-7     Document Type: Review

References (64)

1. T.E. Wilens 2003 Drug treatment for adults with attention deficit hyperactivity disorder Drugs 63 395 2411 10.2165/00003495-200363220-00002 (Pubitemid 37392906)
2. P. Asherson 2005 Clinical assessment and treatment of attention deficit and hyperactivity disorder in adults Expert Rev Neurother 5 25 539 10.1586/14737175.5.4.525 (Pubitemid 41021059)
3. S.V. Faraone T. Spencer M. Aleardi C. Pagano J. Biederman 2004 Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder J Clin Psychopharmacol 24 4 9 10.1097/01.jcp.0000108984.11879.95 (Pubitemid 38134162)
4. J. Biederman T. Spencer T. Wilens 2004 Evidence based pharmacotherapy of attention-deficit/hyperactivity disorder Int J Neuropsychopharmacol 7 7 97 10.1017/S1461145703003973 (Pubitemid 38523811)
5. S.H. Kollins E.K. MacDonald C.R. Rush 2001 Assessing the abuse potential of methylphenidate in non-human and human subjects: a review Pharmacol Biochem Behav 68 11 627 10.1016/S0091-3057(01)00464-6 (Pubitemid 32452420)
6. T. Spencer J. Biederman T. Wilens M. Harding D. O'Donnell S. Griffin 1996 Pharmacotherapy of attention-deficit/hyperactivity disorder across the life cycle: a literature review J Am Acad Child Adolesc Psychiatry 35 9 432
7. T.E. Wilens T.J. Spencer 2000 The stimulants revisited Child Adolesc Psychiatr Clin N Am 9 73 603
8. T. Spencer 2004 Stimulant treatment for adult attentiondeficit/ hyperactivity disorder Psychiatr Clin N Am 27 61 372
9. J.J. McGough S.L. Smalley J.T. McCracken 2005 Psychiatric comorbidity in adult ADHD: findings from multiplex families Am J Psychiatry 162 1621 1627 16135620 10.1176/appi.ajp.162.9.1621 (Pubitemid 41318230)
10. L. Greenhill S. Pliska M.K. Dulcan 2002 Practice parameters for the use of stimulant medication in the treatment of children, adolescent and adults Am Acad Child Adolesc Psychiatry 41 suppl. 26 49
11. K.J. Stone A.J. Viera C.L. Parman 2003 Off-label applications for SSRIs Am Fam Physician 68 98 504
12. H. Chen J.H. Reeves J.E. Finchman W.K. Kennedy J.H. Dorfman B.C. Martin 2006 Off-label use of antidepressants, anticonvulsant, and antipsychotic medications among Georgia Medicaid Enrolees in 2001 J Clin Psychiatry 67 72 982
13. Het doelmatig gebruik van antidepressiva in de behandeling van andere indicaties dan stemmingsstoornissen. Concensus vergadering RIZIV, comité voor de evaluatie van de medische praktijk inzage geneesmiddelen. 2008 Folia Pharmacother 35 4
14. N. Uçeyler W. Häuser C. Sommer 2008 A systematic review on the effectiveness of treatment with fibromyalgia syndrome Arthritis Rheum 59 279 1298 10.1002/art.24000
15. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). The Cochrane Collaboration; 2008. Available at: www.cochrane-handbook.org.
16. T.E. Wilens J. Biederman J. Prince 1996 Sixweek, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder Am J Psychiatry 153 1147 1153 8780417 1:STN:280:BymA2svht1I%3D
17. S. Kuperman P.J. Perry G.R. Gaffney 2001 Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults Ann Clin Psychiatry 13 129 134 11791949 1:STN:280:DC%2BD38%2FmslCitQ%3D%3D
18. T.E. Wilens T.J. Spencer J. Biederman 2001 A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults Am J Psychiatry. 158 282 288 11156812 10.1176/appi.ajp.158.2.282 1:STN:280: DC%2BD3M7ktFKitA%3D%3D (Pubitemid 32116526)
19. M.F. Dorrego L. Canevaro G. Kuzis L. Sabe S.E. Starkstein 2002 A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings J Neuropsychiatry Clin Neurosci 14 289 295 12154153 1:CAS:528:DC%2BD38XmsFaqtrg%3D
20. T.E. Wilens B.R. Haight J.P. Horrigan 2005 Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study Biol Psychiatry 57 793 801 15820237 10.1016/j.biopsych.2005.01.027 1:CAS:528:DC%2BD2MXjtV2jtrw%3D (Pubitemid 40487924)
21. F.W. Reimherr D.W. Hedges R.E. Strong B.K. Marchant E.D. Williams 2005 Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial Neuropsychiatr Dis Treat 1 245 251 18568102 1:CAS:528:DC%2BD28XhtlarsrrL
22. F.R. Levin S.M. Evans D.J. Brooks A.P. Kalbag F. Garawi E.V. Nunes 2006 Treatment of methadone maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo Drug Alcohol Depend. 81 137 148 16102908 10.1016/j.drugalcdep.2005.06.012 1:CAS:528:DC%2BD2MXhtlCrsL7K (Pubitemid 41821797)
23. M. Weiss L. Hechtman 2006 The Adult ADHD Research Group. A randomised double-blind trial of paroxetine and/or dextroamphetamine and problemfocused therapy for attention-deficit/hyperactivity disorder in adults J Clin Psychiatry 67 11 619
24. G. Gobbi S. Slater N. Boucher G. Debonnel P. Blier 2003 Neurochemical and psychotropic effects of bupropion in healthy male subjects J Clin Psychopharmacol 23 33 239 10.1097/00004714-200306000-00004 (Pubitemid 36807790)
25. T.E. Wilens W. Dodson 2004 A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood J Clin Psychiatry 65 301 1313
26. K. Demyttenaere L. Jaspers 2008 Review: bupropion and SSRI-induced side effects J Psychopharmacol 22 92 804 10.1177/0269881107083798
27. Wellbutrin XL (bupropion hydrochloride extendedrelease tablets) prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2005.
28. T. Spencer T. Wilens J. Biederman S.V. Faraone J.S. Ablon K. Lapey 1995 A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder Arch Gen Psychiatry 52 34 443
29. P.H. Wender F.W. Reimherr 1990 Bupropion treatment of attention-deficit hyperactivity disorder in adults Am J Psychiatry 147 18 1020
30. F.R. Levin S.M. Evans D.M. McDowell D.J. Brooks J. Nunes 2002 Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder J Addict Dis 21 1 16 11916368 10.1300/J069v21n02-01 (Pubitemid 35205006)
31. Wilens TE, Prince J, Biederman J, et al. An open study of sustained release bupropion in adults with attention-deficit/hyperactivity disorder and substance use disorders. Presented at the 48th annual meeting of the Academy of Child and Adolescent Psychiatry; October 23-28, 2001; Honolulu, Hawaii.
32. T.E. Wilens J.B. Prince T.E. Spencer 2003 An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder Biol Psychiatry 54 9 16 12842303 10.1016/S0006-3223(02)01664-5 1:CAS:528:DC%2BD3sXkvFyqu7c%3D
33. T.E. Wilens J. Biederman E. Mick T.J. Spencer 1995 A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder J Nerv Ment Dis. 183 8 50
34. S.H. Preskorn E. Weller G. Jerkovich 1988 Depression in children: concentration dependent CNS toxicity of tricyclic antidepressants Psychopharmacol Bull 24 140 142 3387518 1:STN:280:DyaL1c3mtlaksw%3D%3D
35. J. Elia P.J. Ambrosini J.L. Rapaport 1999 Treatment of attention-deficit-hyperactivity disorder N Engl J Med 340 80 788 10.1056/NEJM199903113401007 (Pubitemid 29114298)
36. C.W. Popper 2000 Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder Child Adolesc Psychiatr Clin N Am 9 5 646
37. J.P. Horrigan 2001 Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder Expert Opin Pharmacother 2 73 586 10.1517/14656566.2.4.573 (Pubitemid 32427753)
38. M. Abramowicz 1990 Sudden death in children treated with a tricyclic antidepressant Med Lett Drugs Ther 32 3 54
39. K.D. Wagner M. Fershtman 1993 Potential mechanism of desipramine-related sudden death in children Psychosomatics 34 80 82 8426895 1:STN:280: ByyC2M%2Fht1w%3D
40. C.W. Popper B. Zimnitzky 1995 Sudden death putatively related to desipramine treatment in youth: a fifth case and a review of speculative mechanisms J Child Adolesc Psychopharmacol 5 83 300
41. J. Biederman R. Thisted L. Greenhill N. Ryan 1995 Estimation of the association between desipramine and the risk for sudden death in 5- to 14 year-old children J Clin Psychiatry 56 7 93
42. T.J. Spencer J. Biederman B. Coffey 2002 A doubleblind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder Arch Gen Psychiatry 59 649 656 12090818 10.1001/archpsyc.59.7.649 1:CAS:528:DC%2BD38XlvVSisLw%3D
43. S.R. Pliszka 2003 Non-stimulant treatment of attention deficit hyperactivity disorder CNS Spectrums 8 253 258 12679740
44. Cozza KL, Armstrong SC, Oesterheld JR. Drug Interaction Principles for Medical Practice. Arlington, VA: American Psychiatric Publishing, Inc.; 2003.
45. T.E. Wilens T.J. Spencer J. Biederman 2002 A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder J Atten Disord 5 89 202
46. S.R. Pliszka 2001 New developments in psychopharmacology of attention deficit hyperactivity disorder Expert Opin Investig Drugs 10 797 1807 10.1517/13543784.10.10.1797 (Pubitemid 32982806)
47. F. Arabgol L. Panaghi P. Hebrani 2008 Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder Eur Child Adolesc Psychiatry 18 53 59 18563471 10.1007/s00787-008-0705- 9
48. Double blind, four week trial of [S,S] reboxetine and atomoxetine in adults with ADHD. Clinical Trials. gov web site. Trial no. NCT005620SS. Available at: www.clinicaltrials.gov/ct2/show/NCT005620SS. Accessed October 30 2008.
49. Stahl SM. Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 3rd edition. Cambridge University Press; 2008.
50. M. Ernst L.L. Liebenauer P.H. Jons D. Tebeka R.M. Cohen A.J. Zametkin 1996 Selegeline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety Psychopharmacol Bull 32 27 334
51. P.H. Wender D.R. Wood F.W. Reimherr M. Ward 1983 An open trial of pargyline in the treatment of attention deficit disorder, residual type Psychiatry Res 9 29 336 10.1016/0165-1781(83)90006-9
52. M. Ernst L.L. Liebenauer D. Tebeka 1997 Selegeline in ADHD adults: plasma monoamines and monoamine metabolites Neuropsychopharmacology 16 76 284 10.1016/S0893-133X(96)00243-6 (Pubitemid 27146188)
53. Szabadi E, Bradshaw CM. Seminars in Clinical Psychopharmacology. 2nd edition. London: Royal College of Psychiatrists; 2004.
54. R.D. Oades 2007 The role of the serotonin system in ADHD: treatment implications Expert Rev Neurother 7 357 1374 10.1586/14737175.7.10.1357 (Pubitemid 350012724)
55. C. Damsa A. Bumb F. Bianchi-Demicheli 2004 "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review J Clin Psychiatry 65 1064 1068 15323590 1:CAS:528:DC%2BD2cXnvFKhtrY%3D
56. J.A. Schmitt J.G. Ramaekers M.J. Kruizinga M.P. van Boxtel E.F. Vuurman W.J. Riedel 2002 Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man J Psychopharmacol 16 7 214
57. R. Hoehn-Saric J.R. Lipsey D.R. McLeod 1990 Apathy and indifference in patients on fluvoxamine and fluoxetine J Clin Psychopharmacol 10 43 345 10.1097/00004714-199010000-00007
58. R. Hoehn-Saric G.J. Harris G.D. Pearlson C.S. Cox S.R. Machlin E.E. Camargo 1991 A fluoxetine induced frontal lobe syndrome in an obsessive compulsive patient J Clin Psychiatry 52 31 133
59. C.W. Popper 1997 Antidepressants in the treatment of attention-deficit/ hyperactivity disorder J Clin Psychiatry 58 suppl.14 4 29
60. D. Hedges F.W. Reimherr A. Rogers R. Strong P.H. Wender 1995 An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder Psychopharmacol Bull 31 79 783
61. G.B. Baker R.A. Bornstein A.C. Roujet S.E. Ashton J.C. van Muyden R.T. Coutts 1991 Phenylethylaminergic mechanismens in attention deficit disorder Biol Psychiatry 29 5 22
62. T.R. Berigan 2003 Off-label use of venlafaxine in psychiatric and nonpsychiatric conditions Prim Psychiatry 10 2 116
63. J. Biederman T. Spencer 2004 Psychopharmacology of adults with attention-deficit/hyperactivity disorder Prim Care Companion J Clin Psychiatry 1 7 62
64. K. Peterson M.S. McDonagh R. Fu 2008 Comparative benefits and harms of competing medications for adults with ADHD: a systematic review and indirect comparison meta-analysis Psychopharmacology 197 1 11 18026719 10.1007/s00213-007-0996-4 1:CAS:528:DC%2BD1cXjsVCqsLs%3D